| DC Field | Value | Language |
|---|
| dc.contributor.author | Golubinskaya, P. A. | - |
| dc.contributor.author | Sarycheva, M. V. | - |
| dc.contributor.author | Burda, S. Y. | - |
| dc.contributor.author | Puzanov, M. V. | - |
| dc.contributor.author | Nadezhdina, N. A. | - |
| dc.date.accessioned | 2022-04-26T06:23:19Z | - |
| dc.date.available | 2022-04-26T06:23:19Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | Pharmacological modulation of cell functional activity with valproic acid and erythropoietin / P.A. Golubinskaya [et al.] // Research Results in Pharmacology. - 2019. - Vol. 5, № 2.- P. 89-99. - Doi: 10.3897/rrpharmacology.5.34710. - Refer.: p. 94-98. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46340 | - |
| dc.description.abstract | Valproic acid (VA) is carboxylic acid with a branched chain, which is used as an antiepileptic drug. VA, which is an antiepileptic drug, is also a teratogen, which causes defects of a neural tube and an axial skeleton, although the mechanisms are not yet fully clear. It is shown that valproic acid reduces the intracellular level of oxygen active forms | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | biomedical cellular products | ru |
| dc.subject | valproic acid | ru |
| dc.subject | cell technologies | ru |
| dc.subject | mesenchymal stem cells | ru |
| dc.subject | erythropoietin | ru |
| dc.title | Pharmacological modulation of cell functional activity with valproic acid and erythropoietin | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 5, № 2
|
